These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26384802)

  • 1. Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy: A Review of the Evidence.
    Chapman CH; Jagsi R
    Oncology (Williston Park); 2015 Sep; 29(9):657-66. PubMed ID: 26384802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
    Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
    Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of the axilla before preoperative chemotherapy: implications for postmastectomy radiation.
    Bazan JG; White J
    Cancer; 2015 Apr; 121(8):1187-94. PubMed ID: 25288389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy.
    Nagar H; Boothe D; Ginter PS; Sison C; Vahdat L; Shin S; Smith M; Chao KS; Nori D; Hayes MK
    Clin Breast Cancer; 2015 Apr; 15(2):128-34. PubMed ID: 25459070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.
    Wright JL; Takita C; Reis IM; Zhao W; Saigal K; Wolfson A; Markoe A; Moller M; Hurley J
    Cancer; 2013 Jan; 119(1):16-25. PubMed ID: 22736498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer.
    Fowble BL; Einck JP; Kim DN; McCloskey S; Mayadev J; Yashar C; Chen SL; Hwang ES;
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):494-503. PubMed ID: 22579377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Postmastectomy Radiation Therapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy.
    Bazan JG; White JR
    Semin Radiat Oncol; 2016 Jan; 26(1):51-8. PubMed ID: 26617210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
    Campbell JI; Yau C; Krass P; Moore D; Carey LA; Au A; Chhieng D; Giri D; Livasy C; Mies C; Rabban J; Sarode VR; Singh B; Esserman L; Chen YY
    Breast Cancer Res Treat; 2017 Aug; 165(1):181-191. PubMed ID: 28577078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
    Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
    Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
    Kozak MM; von Eyben R; Gutkin PM; Vemuri M; Jacobson CE; Karl JJ; Walck E; Marquez C; Horst KC
    Clin Breast Cancer; 2021 Aug; 21(4):373-382. PubMed ID: 33766533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].
    Le Scodan R; Bruant S; Selz J; Bollet MA; Daveau C; de la Lande B; Lerebours F; Labib A; Stevens D
    Cancer Radiother; 2011 Dec; 15(8):675-82. PubMed ID: 21831686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
    Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
    Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
    Garg AK; Oh JL; Oswald MJ; Huang E; Strom EA; Perkins GH; Woodward WA; Yu TK; Tereffe W; Meric-Bernstam F; Hahn K; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1478-83. PubMed ID: 17855016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.